C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2002
10/24/2002	US20020156050 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors
10/24/2002	CA2444596A1 Large conductance calcium-activated k channel opener
10/24/2002	CA2444455A1 N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
10/24/2002	CA2443870A1 Cyclohexylphenyl vasopressin agonists
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/23/2002	WO2001095940A1 Sustained release compositions
10/23/2002	EP1251131A2 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
10/23/2002	CN1375495A Light excisable biotinyted reagent and its synthesis and application
10/23/2002	CN1092960C Pharmaceutical composition comprising proteinase inhibitor and monoglyceride
10/23/2002	CA2407472A1 Sustained release compositions
10/22/2002	US6469196 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
10/22/2002	US6469166 Crf receptor antagonists; treatment of endocrine, psychiatric and neurologic conditions or illnesses, including stress-related disorders
10/22/2002	US6469039 Benzimidazoles; thrombin- inhibiting activity and the effect of extending thrombin time
10/22/2002	US6469020 Hydroxamic and carboxylic acid derivatives
10/22/2002	US6469017 Method of inhibiting interleukin-12 signaling
10/22/2002	US6469014 Immunosuppressive activity
10/22/2002	US6469006 Particularly for treating hiv infections
10/22/2002	US6469000 1,3-diheterocyclic metalloprotease inhibitors
10/22/2002	US6468997 Desmethylolanzapine compositions and methods
10/17/2002	WO2002081479A1 Method for the production of 6-aryl-4h-s-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines
10/17/2002	WO2002081398A2 Additives for building industry obtained from by-products and process for their production
10/17/2002	WO2002080927A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/17/2002	WO2002066468A3 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
10/17/2002	US20020151713 Substituted 6,5-hetero-bicyclic derivatives
10/17/2002	US20020151561 Such as 7-(benzoylamino-methyl)-2-(oxalyl-amino)-4,5,6,7-tetrahydro-thieno(2,3 -c)pyridine-3-carboxylic acid for treatment of diabetes, insulin resistance, and obesity
10/17/2002	US20020151553 Such as 4-(4-chlorophenyl)1-(3-(5-cyano-5H-dibenzo(a,d) cycloheptene-5-yl)propyl)piperidin-4-ol for treatment of diseases associated with aberrant leukocyte recruitment and/or activation
10/17/2002	US20020151544 Phosphatidylinositol 3-kinase (PI3K) inhibitors/anticancer agents such as N-(2-(3-benzenesulfonylaminophenyl)-4-morphoniloquinazolin-6-yl)acetamide
10/17/2002	US20020150961 Activity-dependent cysteine protease profiling reagent
10/17/2002	DE10116378A1 Verfahren zur Herstellung von 6-Aryl-4H-s-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepinen A process for the preparation of 6-aryl-4H-s-triazolo [3,4-c] thieno [2,3-e] -1,4-diazepines
10/17/2002	CA2443031A1 Use of selective cox-2 inhibitors for the treatment of urinary incontinence
10/16/2002	EP1248784A1 Condensed azepines as vasopressin agonists
10/16/2002	EP1248780A1 Di(het)arylaminothiophene derivatives
10/16/2002	EP1159279B1 4-oxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
10/16/2002	EP0991653B1 Novel compounds
10/16/2002	EP0831826B1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
10/16/2002	CN1374960A Novel integrain receptor antagonists
10/16/2002	CN1374955A Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
10/16/2002	CN1374312A Syhnthesis of d-biotin
10/15/2002	US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
10/15/2002	US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002	US6465474 Treatment of such as osteoarthitis, rheumatoid arthritis, prevention or arrest of tumor growth and metastasis, corneal ulceration, lack of corneal healing, macular degeneration, periodontal disease, gingivitis
10/10/2002	WO2002079295A1 Thiophenes and polymers derived therefrom
10/10/2002	WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002	WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	WO2002078712A1 Remedies for vesical stimulation in association with prostatauxe
10/10/2002	WO2002078711A1 Remedies for vesical hyperesthesia
10/10/2002	WO2002078710A1 Remedies for vesical hyperactivity
10/10/2002	WO2002078633A2 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
10/10/2002	WO2002078523A2 Agent for the treatment of overactive bladder
10/10/2002	WO2002062764A9 Fused heterocyclic compounds
10/10/2002	WO2001078780A1 Preventives/remedies for alzheimer's disease
10/10/2002	US20020147341 Kinase inhibitor; benign prostatic hyperplasia
10/10/2002	US20020147231 Allosteric adenosine receptor modulators
10/10/2002	US20020147190 Sedatives; sleep disorders
10/10/2002	US20020147188 Protease inhibitors
10/10/2002	US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/10/2002	CA2442476A1 Pyridazinone aldose reductase inhibitors
10/10/2002	CA2442472A1 Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
10/10/2002	CA2442468A1 Therapeutic agent for bladder hypersensitivity
10/10/2002	CA2442463A1 Therapeutic agent for overactive bladder
10/10/2002	CA2442452A1 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
10/10/2002	CA2442437A1 Agent for the treatment of overactive bladder
10/10/2002	CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002	CA2406832A1 Preventives/remedies for alzheimer's disease
10/09/2002	EP1247803A2 Indolinone compounds suitable for modulation of protein kinases
10/09/2002	EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002	EP1246827A1 New polymorphic forms of olanzapine
10/09/2002	EP1246784A1 Reaction of carbonyl compounds with organometallic reagents
10/09/2002	EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002	EP0910381A4 Method for treating pain
10/09/2002	CN1092197C Bicyclic thiophene derivs, and use as gonadotropin releasing hormone antagonists
10/08/2002	US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/03/2002	WO2002076964A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same
10/03/2002	WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002	WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002	US20020143187 Nitric oxide donors and pharmaceutical compositions containing them
10/03/2002	US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002	US20020143004 Allosteric adenosine receptor modulators
10/03/2002	US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses
10/03/2002	CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/02/2002	EP1244675A1 Method for producing thienopyrimidines
10/02/2002	EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002	EP0791000B1 Thienopyridine or thienopyrimidine derivatives and their use
10/02/2002	EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002	CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/01/2002	US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
09/2002
09/26/2002	WO2002074746A1 Benzazepine derivatives
09/26/2002	WO2002074056A2 Allosteric adenosine receptor modulators
09/26/2002	WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002	CA2441563A1 Allosteric adenosine receptor modulators
09/25/2002	EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002	EP1242426A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
09/25/2002	EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers
09/25/2002	EP1242382A1 Tricyclic protein kinase inhibitors
09/25/2002	EP1181279A4 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
09/25/2002	EP0982992B1 Use of thienopyrimidines as fungicides
09/25/2002	EP0923570B1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives
09/25/2002	CN1371374A Substituted heterocycle fused gamma-carbolines
09/24/2002	US6455714 Labeled vitamin D compounds and the use thereof
09/24/2002	US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family

1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 214